美國賓夕法尼亞大學(xué)化學(xué)系2025年博士后招聘
賓夕法尼亞大學(xué) （University of Pennsylvania），簡(jiǎn)稱賓大（UPenn, Penn），位于美國賓夕法尼亞州的費(fèi)城，是一所享譽(yù)世界的私立研究型大學(xué)，常春藤盟校（Ivy League）成員，美國大學(xué)協(xié)會(huì)創(chuàng)始成員，全球大學(xué)校長論壇成員，入選英國政府“高潛力人才簽證計(jì)劃” 院校名單。
Post-Docs in the Virgil Percec lab at the University of Pennsylvania, Department of Chemistry
Employer
University of Pennsylvania, Department of Chemistry
Location
Philadelphia, Pennsylvania (US)
Salary
Commensurate with education and experience
Closing date
Mar 6, 2025
Post-docs in the Virgil Percec Lab at the University of Pennsylvania (Penn), Department of Chemistry in the design, synthesis and structural analysis combined with in vivo activity for one-component delivery systems for mRNA
Virgil Percec Lab together with Drew Weissman Lab from the Perelman School of Medicine at Penn discovered and developed a one-component multifunctional sequence-defined ionizable amphiphilic Janus dendrimer (IAJD) delivery system for mRNA (JACS 2021, 143, 12315). IAJDs co-assemble with mRNA into dendrimersome nanoparticles (DNPs) which eliminate some of the disadvantages and complement the four-component lipid nanoparticles (LNPs) elaborated and employed in the delivery of mRNA from Covid 19 vaccines. These postdoc positions are immediately available and require excellent background in organic synthesis, supramolecular chemistry and characterization by NMR, HPLC, MALDI-TOF combined with in vivo experiments performed in collaboration with Weissman Laboratory. The goal of these positions is to develop a Nanoperiodic Table correlating the primary structure of IAJDs with in vivo mRNA delivery. This work is expected to impact the new field of nanomedicine by creating new, less expensive and more activer vaccines and therapeutics based on mRNA
為防止簡(jiǎn)歷投遞丟失請(qǐng)抄送一份至：boshijob@126.com（郵件標(biāo)題格式：應(yīng)聘職位名稱+姓名+學(xué)歷+專業(yè)+中國博士人才網(wǎng)）
中國-博士人才網(wǎng)發(fā)布
聲明提示：凡本網(wǎng)注明“來源：XXX”的文/圖等稿件，本網(wǎng)轉(zhuǎn)載出于傳遞更多信息及方便產(chǎn)業(yè)探討之目的，并不意味著本站贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性，文章內(nèi)容僅供參考。
